28 results on '"Motiño, Omar"'
Search Results
2. 3,4-dimethoxychalcone induces autophagy and reduces neointimal hyperplasia and aortic lesions in mouse models of atherosclerosis
- Author
-
Cerrato, Giulia, Alvarez-Lucena, Carlota, Sauvat, Allan, Hu, Yanhua, Forveille, Sabrina, Chen, Guo, Durand, Sylvère, Aprahamian, Fanny, Leduc, Marion, Motiño, Omar, Boscá, Lisardo, Xu, Qingbo, Kepp, Oliver, and Kroemer, Guido
- Published
- 2023
- Full Text
- View/download PDF
3. Obesity-Associated Colorectal Cancer.
- Author
-
Gonzalez-Gutierrez, Lucia, Motiño, Omar, Barriuso, Daniel, de la Puente-Aldea, Juan, Alvarez-Frutos, Lucia, Kroemer, Guido, Palacios-Ramirez, Roberto, and Senovilla, Laura
- Subjects
- *
EPIDEMIOLOGY of cancer , *COLORECTAL cancer , *MOLECULAR epidemiology , *CANCER invasiveness , *DRUG target - Abstract
Colorectal cancer (CRC) affects approximately 2 million people worldwide. Obesity is the major risk factor for CRC. In addition, obesity contributes to a chronic inflammatory stage that enhances tumor progression through the secretion of proinflammatory cytokines. In addition to an increased inflammatory response, obesity-associated cancer presents accrued molecular factors related to cancer characteristics, such as genome instability, sustained cell proliferation, telomere dysfunctions, angiogenesis, and microbial alteration, among others. Despite the evidence accumulated over the last few years, the treatments for obesity-associated CRC do not differ from the CRC treatments in normal-weight individuals. In this review, we summarize the current knowledge on obesity-associated cancer, including its epidemiology, risk factors, molecular factors, and current treatments. Finally, we enumerate possible new therapeutic targets that may improve the conditions of obese CRC patients. Obesity is key for the development of CRC, and treatments resulting in the reversal of obesity should be considered as a strategy for improving antineoplastic CRC therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Acyl-CoA binding protein for the experimental treatment of anorexia.
- Author
-
Chen, Hui, Moriceau, Stéphanie, Joseph, Adrien, Mailliet, Francois, Li, Sijing, Tolle, Virginie, Duriez, Philibert, Dardennes, Roland, Durand, Sylvère, Carbonnier, Vincent, Stoll, Gautier, Sauvat, Allan, Lachkar, Sylvie, Aprahamian, Fanny, Alves Costa Silva, Carolina, Pan, Hui, Montégut, Léa, Anagnostopoulos, Gerasimos, Lambertucci, Flavia, and Motiño, Omar
- Subjects
CARRIER proteins ,MELANOCORTIN receptors ,EATING disorders ,PEPTIDES ,ANOREXIA nervosa ,PACLITAXEL - Abstract
Extracellular acyl-coenzyme A binding protein [ACBP encoded by diazepam binding inhibitor (DBI)] is a phylogenetically ancient appetite stimulator that is secreted in a nonconventional, autophagy-dependent fashion. Here, we show that low ACBP/DBI plasma concentrations are associated with poor prognosis in patients with anorexia nervosa, a frequent and often intractable eating disorder. In mice, anorexia induced by chronic restraint stress (CRS) is accompanied by a reduction in circulating ACBP/DBI concentrations. We engineered a chemical-genetic system for the secretion of ACBP/DBI through a biotin-activatable, autophagy-independent pathway. In transgenic mice expressing this system in hepatocytes, biotin-induced elevations in plasma ACBP/DBI concentrations prevented anorexia induced by CRS or chemotherapeutic agents including cisplatin, doxorubicin, and paclitaxel. ACBP/DBI reversed the CRS or cisplatin-induced increase in plasma lipocalin-2 concentrations and the hypothalamic activation of anorexigenic melanocortin 4 receptors, for which lipocalin-2 is an agonist. Daily intravenous injections of recombinant ACBP/DBI protein or subcutaneous implantation of osmotic pumps releasing recombinant ACBP/DBI mimicked the orexigenic effects of the chemical-genetic system. In conclusion, the supplementation of extracellular and peripheral ACBP/DBI might constitute a viable strategy for treating anorexia. Editor's summary: Despite its seriousness, anorexia nervosa has limited treatment options. Chen et al. report that acyl CoA binding protein (ACBP), a conserved peptide known to induce hunger, is particularly low in hospitalized anorexic patients with poor prognosis. Administration of ACBP by chemogenetic, daily intravenous, or subcutaneous osmotic pump approaches in mouse models of stress- or chemotherapy-induced anorexia promoted food intake, suggesting the peptide as a potential treatment option for anorexia nervosa. Although ACBP treatment led to dampened hypothalamic MC4R signaling in the mice, the protein did not cross the blood-brain barrier. Its complete mechanism of action thus remains to be elucidated. —Catherine Charneski [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. An obesogenic feedforward loop involving PPARγ, acyl-CoA binding protein and GABAA receptor
- Author
-
Anagnostopoulos, Gerasimos, Motiño, Omar, Li, Sijing, Carbonnier, Vincent, Chen, Hui, Sica, Valentina, Durand, Sylvère, Bourgin, Mélanie, Aprahamian, Fanny, Nirmalathasan, Nitharsshini, Donne, Romain, Desdouets, Chantal, Sola, Marcelo Simon, Kotta, Konstantina, Montégut, Léa, Lambertucci, Flavia, Surdez, Didier, Sandrine, Grossetête, Delattre, Olivier, Maiuri, Maria Chiara, Bravo-San Pedro, José Manuel, Martins, Isabelle, and Kroemer, Guido
- Published
- 2022
- Full Text
- View/download PDF
6. Inhibition of acyl-CoA binding protein (ACBP) by means of a GABAARγ2-derived peptide.
- Author
-
Anagnostopoulos, Gerasimos, Saavedra, Ester, Lambertucci, Flavia, Motiño, Omar, Dimitrov, Jordan, Roiz-Valle, David, Quesada, Victor, Alvarez-Valadez, Karla, Chen, Hui, Sauvat, Allan, Rong, Yan, Nogueira-Recalde, Uxía, Li, Sijing, Montégut, Léa, Djavaheri-Mergny, Mojgan, Castedo, Maria, Lopez-Otin, Carlos, Maiuri, Maria Chiara, Martins, Isabelle, and Kroemer, Guido
- Published
- 2024
- Full Text
- View/download PDF
7. Paradoxical implication of BAX/BAK in the persistence of tetraploid cells
- Author
-
Deng, Jiayin, Gutiérrez, Lucía G., Stoll, Gautier, Motiño, Omar, Martins, Isabelle, Núñez, Lucía, Bravo-San Pedro, José Manuel, Humeau, Juliette, Bordenave, Chloé, Pan, Juncheng, Fohrer-Ting, Hélène, Souquere, Sylvie, Pierron, Gerard, Hetz, Claudio, Villalobos, Carlos, Kroemer, Guido, and Senovilla, Laura
- Published
- 2021
- Full Text
- View/download PDF
8. Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index
- Author
-
Joseph, Adrien, Chen, Hui, Anagnostopoulos, Gerasimos, Montégut, Léa, Lafarge, Antoine, Motiño, Omar, Castedo, Maria, Maiuri, Maria Chiara, Clément, Karine, Terrisse, Safae, Martin, Anne Laure, Vaz-Luis, Ines, Andre, Fabrice, Grundler, Franziska, de Toledo, Françoise Wilhelmi, Madeo, Frank, Zitvogel, Laurence, Goldwasser, François, Blanchet, Benoit, Fumeron, Frédéric, Roussel, Ronan, Martins, Isabelle, and Kroemer, Guido
- Published
- 2021
- Full Text
- View/download PDF
9. Acyl coenzyme A binding protein (ACBP): An aging‐ and disease‐relevant "autophagy checkpoint".
- Author
-
Montégut, Léa, Abdellatif, Mahmoud, Motiño, Omar, Madeo, Frank, Martins, Isabelle, Quesada, Victor, López‐Otín, Carlos, and Kroemer, Guido
- Subjects
CARRIER proteins ,AUTOPHAGY ,GABA ,PEPTIDES ,CENTRAL nervous system ,ACYLTRANSFERASES ,G protein coupled receptors - Abstract
Acyl coenzyme A binding protein (ACBP), also known as diazepam‐binding inhibitor (DBI), is a phylogenetically ancient protein present in some eubacteria and the entire eukaryotic radiation. In several eukaryotic phyla, ACBP/DBI transcends its intracellular function in fatty acid metabolism because it can be released into the extracellular space. This ACBP/DBI secretion usually occurs in response to nutrient scarcity through an autophagy‐dependent pathway. ACBP/DBI and its peptide fragments then act on a range of distinct receptors that diverge among phyla, namely metabotropic G protein‐coupled receptor in yeast (and likely in the mammalian central nervous system), a histidine receptor kinase in slime molds, and ionotropic gamma‐aminobutyric acid (GABA)A receptors in mammals. Genetic or antibody‐mediated inhibition of ACBP/DBI orthologs interferes with nutrient stress‐induced adaptations such as sporulation or increased food intake in multiple species, as it enhances lifespan or healthspan in yeast, plant leaves, nematodes, and multiple mouse models. These lifespan and healthspan‐extending effects of ACBP/DBI suppression are coupled to the induction of autophagy. Altogether, it appears that neutralization of extracellular ACBP/DBI results in "autophagy checkpoint inhibition" to unleash the anti‐aging potential of autophagy. Of note, in humans, ACBP/DBI levels increase in various tissues, as well as in the plasma, in the context of aging, obesity, uncontrolled infection or cardiovascular, inflammatory, neurodegenerative, and malignant diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Protein regulator of cytokinesis 1: a potential oncogenic driver.
- Author
-
Li, Sijing, Motiño, Omar, Lambertucci, Flavia, Martins, Isabelle, Sun, Li, and Kroemer, Guido
- Subjects
- *
CYTOKINESIS , *TH2 cells , *IMMUNE checkpoint proteins , *CELL migration , *CELL cycle , *AGENESIS of corpus callosum - Abstract
Protein regulator of cytokinesis 1 (PRC1) is involved in cytokinesis. Growing evidence suggests the association of PRC1 with multiple cancers. Here, we unveil that, in 28 cancer types, PRC1 is higher expressed in tumor tissues than in non-malignant tissues. Overexpression of PRC1 indicates unfavorable prognostic value, especially in ACC, LGG, KIRP, LICH, LUAD, MESO, PAAD, SARC and UCEC, while methylation of the PRC1 gene at sites associated with its inactivation has a favorable prognostic value in ACC, KIRP, LUAD, MESO, KIRP and LGG. Differentially expressed genes (DEGs) associated with high (> median) PRC1 expression contribute to key signaling pathways related with cell cycle, DNA damage and repair, EMT, cell migration, invasion and cell proliferation in most cancer types. More specifically, the DEGs involved in RAS/RAF/MAPK, PI3K/AKT, WNT, NOTCH, TGF-β, integrin, EMT process, focal adhesion, RHO GTPase-related pathway or microtubule cytoskeleton regulation are upregulated when PRC1 expression is above median, as confirmed for most cancers. Most importantly, high expression of PRC1 appears to be associated with an overabundance of poor-prognosis TH2 cells. Furthermore, positive correlations of PRC1 and some immune checkpoint genes (CD274, CTLA4, HAVCR2, LAG3, PDCD1, PDCD1LG2, TIGIT, and CD86) were observed in several cancers, especially BLCA, BRCA, KIRC, LUAD, LIHC, PRAD and THCA. These findings plead in favor of further studies validating the diagnostic and prognostic impact of PRC1 as well as the elaboration of pharmacological strategies for targeting PRC1. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. Full-Spectrum CARS Microscopy of Cells and Tissues with Ultrashort White-Light Continuum Pulses.
- Author
-
Vernuccio, Federico, Vanna, Renzo, Ceconello, Chiara, Bresci, Arianna, Manetti, Francesco, Sorrentino, Salvatore, Ghislanzoni, Silvia, Lambertucci, Flavia, Motiño, Omar, Martins, Isabelle, Kroemer, Guido, Bongarzone, Italia, Cerullo, Giulio, and Polli, Dario
- Published
- 2023
- Full Text
- View/download PDF
12. Involvement of Bcl-2 Family Proteins in Tetraploidization-Related Senescence.
- Author
-
Barriuso, Daniel, Alvarez-Frutos, Lucia, Gonzalez-Gutierrez, Lucia, Motiño, Omar, Kroemer, Guido, Palacios-Ramirez, Roberto, and Senovilla, Laura
- Subjects
BCL-2 proteins ,AGING ,PROTEIN expression ,TETRAPLOIDY ,CANCER cells - Abstract
The B-cell lymphoma 2 (Bcl-2) family of proteins is the main regulator of apoptosis. However, multiple emerging evidence has revealed that Bcl-2 family proteins are also involved in cellular senescence. On the one hand, the different expression of these proteins determines the entry into senescence. On the other hand, entry into senescence modulates the expression of these proteins, generally conferring resistance to apoptosis. With some exceptions, senescent cells are characterized by the upregulation of antiapoptotic proteins and downregulation of proapoptotic proteins. Under physiological conditions, freshly formed tetraploid cells die by apoptosis due to the tetraploidy checkpoint. However, suppression of Bcl-2 associated x protein (Bax), as well as overexpression of Bcl-2, favors the appearance and survival of tetraploid cells. Furthermore, it is noteworthy that our laboratory has shown that the joint absence of Bax and Bcl-2 antagonist/killer (Bak) favors the entry into senescence of tetraploid cells. Certain microtubule inhibitory chemotherapies, such as taxanes and vinca alkaloids, induce the generation of tetraploid cells. Moreover, the combined use of inhibitors of antiapoptotic proteins of the Bcl-2 family with microtubule inhibitors increases their efficacy. In this review, we aim to shed light on the involvement of the Bcl-2 family of proteins in the senescence program activated after tetraploidization and the possibility of using this knowledge to create a new therapeutic strategy targeting cancer cells. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
13. Benznidazole, the trypanocidal drug used for Chagas disease, induces hepatic NRF2 activation and attenuates the inflammatory response in a murine model of sepsis
- Author
-
Lambertucci, Flavia, Motiño, Omar, Villar, Silvina, Rigalli, Juan Pablo, de Luján Alvarez, María, Catania, Viviana A, Martín-Sanz, Paloma, Carnovale, Cristina Ester, Quiroga, Ariel Darío, Francés, Daniel Eleazar, and Ronco, María Teresa
- Published
- 2017
- Full Text
- View/download PDF
14. High plasma concentrations of acyl‐coenzyme A binding protein (ACBP) predispose to cardiovascular disease: Evidence for a phylogenetically conserved proaging function of ACBP.
- Author
-
Montégut, Léa, Joseph, Adrien, Chen, Hui, Abdellatif, Mahmoud, Ruckenstuhl, Christoph, Motiño, Omar, Lambertucci, Flavia, Anagnostopoulos, Gerasimos, Lachkar, Sylvie, Dichtinger, Silvia, Maiuri, Maria Chiara, Goldwasser, François, Blanchet, Benoit, Fumeron, Frédéric, Martins, Isabelle, Madeo, Frank, and Kroemer, Guido
- Subjects
CARRIER proteins ,AGE ,MONOCLONAL antibodies ,CARDIOVASCULAR diseases ,SYSTOLIC blood pressure ,CARDIOVASCULAR diseases risk factors ,BODY mass index ,HIGH density lipoproteins - Abstract
Autophagy defects accelerate aging, while stimulation of autophagy decelerates aging. Acyl‐coenzyme A binding protein (ACBP), which is encoded by a diazepam‐binding inhibitor (DBI), acts as an extracellular feedback regulator of autophagy. As shown here, knockout of the gene coding for the yeast orthologue of ACBP/DBI (ACB1) improves chronological aging, and this effect is reversed by knockout of essential autophagy genes (ATG5, ATG7) but less so by knockout of an essential mitophagy gene (ATG32). In humans, ACBP/DBI levels independently correlate with body mass index (BMI) as well as with chronological age. In still‐healthy individuals, we find that high ACBP/DBI levels correlate with future cardiovascular events (such as heart surgery, myocardial infarction, and stroke), an association that is independent of BMI and chronological age, suggesting that ACBP/DBI is indeed a biomarker of "biological" aging. Concurringly, ACBP/DBI plasma concentrations correlate with established cardiovascular risk factors (fasting glucose levels, systolic blood pressure, total free cholesterol, triglycerides), but are inversely correlated with atheroprotective high‐density lipoprotein (HDL). In mice, neutralization of ACBP/DBI through a monoclonal antibody attenuates anthracycline‐induced cardiotoxicity, which is a model of accelerated heart aging. In conclusion, plasma elevation of ACBP/DBI constitutes a novel biomarker of chronological aging and facets of biological aging with a prognostic value in cardiovascular disease. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
15. ACBP/DBI protein neutralization confers autophagy-dependent organ protection through inhibition of cell loss, inflammation, and fibrosis.
- Author
-
Motiño, Omar, Lambertucci, Flavia, Anagnostopoulos, Gerasimos, Sijing Li, Nah, Jihoon, Castoldi, Francesca, Senovilla, Laura, Montègut, Lèa, Hui Chen, Durand, Sylvère, Bourgin, Mèlanie, Aprahamian, Fanny, Nirmalathasan, Nitharsshini, Alvarez-Valadez, Karla, Sauvat, Allan, Carbonnier, Vincent, Djavaheri-Mergny, Mojgan, Pietrocola, Federico, Sadoshima, Junichi, and Maiuri, Maria Chiara
- Subjects
- *
CONCANAVALIN A , *HEPATIC fibrosis , *REPERFUSION injury , *FATTY acid oxidation , *PULMONARY fibrosis - Abstract
Acyl-coenzyme A (CoA)–binding protein (ACBP), also known as diazepam-binding inhibitor (DBI), is an extracellular feedback regulator of autophagy. Here, we report that injection of a monoclonal antibody neutralizing ACBP/DBI (α-DBI) protects the murine liver against ischemia/reperfusion damage, intoxication by acetaminophen and concanavalin A, and nonalcoholic steatohepatitis caused by methionine/cholinedeficient diet as well as against liver fibrosis induced by bile duct ligation or carbon tetrachloride. α-DBI downregulated proinflammatory and profibrotic genes and upregulated antioxidant defenses and fatty acid oxidation in the liver. The hepatoprotective effects of α-DBI were mimicked by the induction of ACBP/DBI-specific autoantibodies, an inducible Acbp/Dbi knockout or a constitutive Gabrg2F77I mutation that abolishes ACBP/DBI binding to the GABAA receptor. Liver-protective α-DBI effects were lost when autophagy was pharmacologically blocked or genetically inhibited by knockout of Atg4b. Of note, α-DBI also reduced myocardium infarction and lung fibrosis, supporting the contention that it mediates broad organ-protective effects against multiple insults. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. Hepatic Cyclooxygenase-2 Expression Protects Against Diet-Induced Steatosis, Obesity, and Insulin Resistance
- Author
-
Francés, Daniel E., Motiño, Omar, Agrá, Noelia, González-Rodríguez, Águeda, Fernández-Álvarez, Ana, Cucarella, Carme, Mayoral, Rafael, Castro-Sánchez, Luis, García-Casarrubios, Ester, Boscá, Lisardo, Carnovale, Cristina E., Casado, Marta, Valverde, Ángela M., and Martín-Sanz, Paloma
- Published
- 2015
- Full Text
- View/download PDF
17. Cardio-, hepato- and pneumoprotective effects of autophagy checkpoint inhibition by targeting DBI/ACBP.
- Author
-
Motiño, Omar, Lambertucci, Flavia, Anagnostopoulos, Gerasimos, Li, Sijing, Martins, Isabelle, and Kroemer, Guido
- Published
- 2023
- Full Text
- View/download PDF
18. An obesogenic feedforward loop involving PPARγ, acyl-CoA binding protein and GABAA receptor.
- Author
-
Anagnostopoulos, Gerasimos, Motiño, Omar, Li, Sijing, Carbonnier, Vincent, Chen, Hui, Sica, Valentina, Durand, Sylvère, Bourgin, Mélanie, Aprahamian, Fanny, Nirmalathasan, Nitharsshini, Donne, Romain, Desdouets, Chantal, Sola, Marcelo Simon, Kotta, Konstantina, Montégut, Léa, Lambertucci, Flavia, Surdez, Didier, Sandrine, Grossetête, Delattre, Olivier, and Maiuri, Maria Chiara
- Published
- 2022
- Full Text
- View/download PDF
19. EGF promotes neuroendocrine-like differentiation of prostate cancer cells in the presence of LY294002 through increased ErbB2 expression independent of the phosphatidylinositol 3-kinase-AKT pathway
- Author
-
Cortés, M.Alicia, Cariaga-Martinez, Ariel E., Lobo, María V.T., Martín Orozco, Rosa M., Motiño, Omar, Rodríguez-Ubreva, F.Javier, Angulo, Javier, López-Ruiz, Pilar, and Colás, Begoña
- Published
- 2012
- Full Text
- View/download PDF
20. Antibody-mediated neutralization of ACBP/DBI has anorexigenic and lipolytic effects.
- Author
-
Sica, Valentina, Martins, Isabelle, Motiño, Omar, Bravo-San Pedro, José M., and Kroemer, Guido
- Subjects
FREE fatty acids ,WHITE adipose tissue ,MONOCLONAL antibodies ,FOOD consumption ,INJECTIONS - Abstract
We recently identified acyl coenzyme A-binding protein (ACBP)/diazepam binding inhibitor (DBI) as a novel 'hunger factor': a protein that is upregulated in human or murine obesity and that, if administered to mice, causes hyperphagy, adipogenesis and obesity. Conversely, neutralization of ACBP/DBI by systemic injection of neutralizing monoclonal antibodies or autoantibodies produced after auto-immunization against ACBP/DBI has anorexigenic and lipolytic effects. Thus, neutralization of ACBP/DBI results in reduced food intake subsequent to the activation of anorexigenic neurons and the inactivation of orexigenic neurons in the hypothalamus. Moreover, ACBP/DBI neutralization results into enhanced triglyceride lipolysis in white fat, a surge in free fatty acids in the plasma, enhanced incorporation of glycerol-derived carbon atoms into glucose, as well as an increase in β-oxidation, resulting in a net reduction of fat mass. Importantly, ACBP/DBI neutralization also stimulated an increase in autophagy in various organs, suggesting that it might mediate anti-ageing effects. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
21. Protective Role of Hepatocyte Cyclooxygenase‐2 Expression Against Liver Ischemia–Reperfusion Injury in Mice.
- Author
-
Motiño, Omar, Francés, Daniel E., Casanova, Natalia, Fuertes‐Agudo, Marina, Cucarella, Carme, Flores, Juana M., Vallejo‐Cremades, María Teresa, Olmedilla, Luis, Pérez Peña, José, Bañares, Rafael, Boscá, Lisardo, Casado, Marta, and Martín‐Sanz, Paloma
- Published
- 2019
- Full Text
- View/download PDF
22. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice.
- Author
-
Motiño, Omar, Agra, Noelia, Brea Contreras, Rocío, Domínguez-Moreno, Marina, García-Monzón, Carmelo, Vargas-Castrillón, Javier, Carnovale, Cristina E., Boscá, Lisardo, Casado, Marta, Mayoral, Rafael, Valdecantos, M. Pilar, Valverde, Ángela M., Francés, Daniel E., and Martín-Sanz, Paloma
- Subjects
- *
CYCLOOXYGENASE 2 , *LIVER cells , *FATTY liver , *CARBON tetrachloride , *LABORATORY mice - Abstract
Cyclooxygenase-2 (COX-2) is involved in different liver diseases but little is known about the significance of COX-2 in the development and progression of non-alcoholic steatohepatitis (NASH). This study was designed to elucidate the role of COX-2 expression in hepatocytes in the pathogenesis of steatohepatitis and hepatic fibrosis. In the present work, hepatocyte-specific COX-2 transgenic mice (hCOX-2-Tg) and their wild-type (Wt) littermates were either fed methionine-and-choline deficient (MCD) diet to establish an experimental non-alcoholic steatohepatitis (NASH) model or injected with carbon tetrachloride (CCl 4 ) to induce liver fibrosis. In our animal model, hCOX-2-Tg mice fed MCD diet showed lower grades of steatosis, ballooning and inflammation than Wt mice, in part by reduced recruitment and infiltration of hepatic macrophages, with a corresponding decrease in serum levels of pro-inflammatory cytokines. Furthermore, hCOX-2-Tg mice showed a significant attenuation of the MCD diet-induced increase in oxidative stress and hepatic apoptosis observed in Wt mice. Even more, hCOX-2-Tg mice treated with CCl 4 had significantly lower stages of fibrosis and less hepatic content of collagen, hydroxyproline and pro-fibrogenic markers than Wt controls. Collectively, our data indicates that constitutive hepatocyte COX-2 expression ameliorates NASH and liver fibrosis development in mice by reducing inflammation, oxidative stress and apoptosis and by modulating activation of hepatic stellate cells, respectively, suggesting a possible protective role for COX-2 induction in NASH/NAFLD progression. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
23. Alternative Splicing of Neuronal Differentiation Factor TRF2 Regulated by HNRNPH1/H2.
- Author
-
Grammatikakis, Ioannis, Zhang, Peisu, Panda, Amaresh C., Kim, Jiyoung, Maudsley, Stuart, Abdelmohsen, Kotb, Yang, Xiaoling, Martindale, Jennifer L., Motiño, Omar, Hutchison, Emmette R., Mattson, Mark P., and Gorospe, Myriam
- Abstract
Summary During neuronal differentiation, use of an alternative splice site on the rat telomere repeat-binding factor 2 (TRF2) mRNA generates a short TRF2 protein isoform (TRF2-S) capable of derepressing neuronal genes. However, the RNA-binding proteins (RBPs) controlling this splicing event are unknown. Here, using affinity pull-down analysis, we identified heterogeneous nuclear ribonucleoproteins H1 and H2(HNRNPH) as RBPs specifically capable of interacting with the spliced RNA segment (exon 7) of Trf2 pre-mRNA. HNRNPH proteins prevent the production of the short isoform of Trf2 mRNA, as HNRNPH silencing selectively elevates TRF2-S levels. Accordingly, HNRNPH levels decline while TRF2-S levels increase during neuronal differentiation. In addition, CRISPR/Cas9-mediated deletion of hnRNPH2 selectively accelerates the NGF-triggered differentiation of rat pheochromocytoma cells into neurons. In sum, HNRNPH is a splicing regulator of Trf2 pre-mRNA that prevents the expression of TRF2-S, a factor implicated in neuronal differentiation. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
24. Regulation of MicroRNA 183 by Cyclooxygenase 2 in Liver Is DEAD-Box Helicase p68 (DDX5) Dependent: Role in Insulin Signaling.
- Author
-
Motiño, Omar, Francés, Daniel E., Mayoral, Rafael, Castro-Sánchez, Luis, Fernández-Velasco, María, Boscá, Lisardo, García-Monzón, Carmelo, Brea, Rocío, Casado, Marta, Agra, Noelia, and Martín-Sanz, Paloma
- Subjects
- *
MICRORNA , *CYCLOOXYGENASE 2 , *LIVER , *HELICASES , *LIVER cells , *INSULIN resistance , *PHOSPHATIDYLINOSITOLS - Abstract
Cyclooxygenase (COX) catalyzes the first step in prostanoid biosynthesis and exists as two isoforms. COX-1 is a constitutive enzyme involved in physiological processes, whereas COX-2 is induced by a variety of stimuli. MicroRNAs (miRNAs) are noncoding RNAs that function as key posttranscriptional regulators of gene expression. Although it is known that COX-2 expression is regulated by miRNAs, there are no data regarding COX-2 involvement in miRNA regulation. Considering our previous results showing that COX-2 expression in hepatocytes protects against insulin resistance, we evaluated the role of COX-2 in the regulation of a specific set of miRNAs implicated in insulin signaling in liver cells. Our results provide evidence of the molecular basis for a novel function of COX-2 in miRNA processing. COX-2 represses miRNA 23b (miR-23b), miR-146b, and miR-183 expression in liver cells by increasing the level of DEAD-box helicase p68 (DDX5) through phosphatidylinositol 3-kinase (PI3K)/p300 signaling and by modulating the enzymatic function of the Drosha (RNase type III) complex through its physical association with DDX5. The decrease of miR-183 expression promotes protection against insulin resistance by increasing insulin receptor substrate 1 (IRS1) levels. These results indicate that the modulation of miRNA processing by COX-2 is a key event in insulin signaling in liver and has potential clinical implications for the management of various hepatic dysfunctions. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
25. Cyclooxygenase-2 Is a Target of MicroRNA-16 in Human Hepatoma Cells.
- Author
-
Andrieu, Noelia Agra, Motiño, Omar, Mayoral, Rafael, Izquierdo, Cristina Llorente, Fernández-Alvarez, Ana, Boscá, Lisardo, Casado, Marta, and Martín-Sanz, Paloma
- Subjects
- *
CYCLOOXYGENASES , *CELL lines , *HEPATOCELLULAR carcinoma , *LIVER cancer , *TUMORS , *CELL growth - Abstract
Cyclooxygenase-2 (COX-2) expression has been detected in human hepatoma cell lines and in human hepatocellular carcinoma (HCC); however, the contribution of COX-2 to the development of HCC remains controversial. COX-2 expression is higher in the non-tumoral tissue and inversely correlates with the differentiation grade of the tumor. COX-2 expression depends on the interplay between different cellular pathways involving both transcriptional and post-transcriptional regulation. The aim of this work was to assess whether COX-2 could be regulated by microRNAs in human hepatoma cell lines and in human HCC specimens since these molecules contribute to the regulation of genes implicated in cell growth and differentiation. Our results show that miR-16 silences COX-2 expression in hepatoma cells by two mechanisms: a) by binding directly to the microRNA response element (MRE) in the COX-2 3'-UTR promoting translational suppression of COX- 2 mRNA; b) by decreasing the levels of the RNA-binding protein Human Antigen R (HuR). Furthermore, ectopic expression of miR-16 inhibits cell proliferation, promotes cell apoptosis and suppresses the ability of hepatoma cells to develop tumors in nude mice, partially through targeting COX-2. Moreover a reduced miR-16 expression tends to correlate to high levels of COX-2 protein in liver from patients affected by HCC. Our data show an important role for miR-16 as a post-transcriptional regulator of COX-2 in HCC and suggest the potential therapeutic application of miR-16 in those HCC with a high COX-2 expression. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
26. Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet.
- Author
-
Lambertucci, Flavia, Arboatti, Ainelén, Sedlmeier, María Guillermina, Motiño, Omar, Alvarez, María De Luján, Ceballos, María Paula, Villar, Silvina R., Roggero, Eduardo, Monti, Juan A., Pisani, Gerardo, Quiroga, Ariel D., Martín-Sanz, Paloma, Carnovale, Cristina Ester, Francés, Daniel Eleazar, and Ronco, María Teresa
- Subjects
- *
TUMOR necrosis factors , *LABORATORY mice , *OBESITY , *CYTOKINES , *INSULIN resistance , *INTERLEUKIN-1 , *ANIMAL experimentation , *APOPTOSIS , *CELL receptors , *CELLULAR signal transduction , *COMPARATIVE studies , *DIET , *FATTY liver , *INSULIN , *LIVER , *MACROPHAGES , *RESEARCH methodology , *MEDICAL cooperation , *MICE , *RESEARCH , *EVALUATION research - Abstract
Obesity is accompanied by a low-grade inflammation state, characterized by increased proinflammatory cytokines levels such as tumor necrosis factor alpha (TNFα) and interleukin-1 beta (IL-1β). In this regard, there exists a lack of studies in hepatic tissue about the role of TNFα receptor 1 (TNFR1) in the context of obesity and insulin resistance during the progression of nonalcoholic fatty liver disease (NAFLD). The aim of this work was to evaluate the effects of high-caloric feeding (HFD) (40% fat, for 16 weeks) on liver inflammation-induced apoptosis, insulin resistance, hepatic lipid accumulation and its progression toward nonalcoholic steatohepatitis (NASH) in TNFR1 knock-out and wild-type mice. Mechanisms involved in HFD-derived IL-1β release and impairment of insulin signaling are still unknown, so we determined whether IL-1β affects liver insulin sensitivity and apoptosis through TNFα receptor 1 (TNFR1)-dependent pathways. We showed that knocking out TNFR1 induces an enhanced IL-1β plasmatic release upon HFD feed. This was correlated with higher hepatic and epididymal white adipose tissue mRNA levels. In vivo and in vitro assays confirmed an impairment in hepatic insulin signaling, in part due to IL-1β-induced decrease of AKT activation and diminution of IRS1 levels, followed by an increase in inflammation, macrophage (resident and recruited) accumulation, hepatocyte apoptotic process and finally hepatic damage. In addition, TNFR1 KO mice displayed higher levels of pro-fibrogenic markers. TNFR1 signaling disruption upon an HFD leads to an accelerated progression from simple steatosis to a more severe phenotype with many NASH features, pointing out a key role of TNFR1 in NAFLD progression. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
27. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma.
- Author
-
Castro-Sánchez, Luis, Agra, Noelia, Llorente Izquierdo, Cristina, Motiño, Omar, Casado, Marta, Boscá, Lisardo, and Martín-Sanz, Paloma
- Subjects
- *
PROSTAGLANDIN synthesis , *DEHYDROGENASES , *LIVER cancer , *CYCLOOXYGENASE 2 , *ARACHIDONIC acid , *GROWTH factors - Abstract
Abstract: Cyclooxygenase-2 (COX-2), a rate limiting step in arachidonic acid cascade, plays a key role in the biosynthesis of prostaglandin E2 (PGE2) upon inflammatory stimuli, growth factors, hormones and other cellular stresses. Overproduction of PGE2 stimulates proliferation of various cancer cells, confers resistance to apoptosis and favors metastasis and angiogenesis. The steady-state level of PGE2 is maintained by interplay between the biosynthetic pathway including COX and PGE2 synthases and the catabolic pathways involving nicotinamide adenine dinucleotide (NAD+)-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH). 15-PGDH is a crucial enzyme responsible for the biological inactivation of PGE2. Adult hepatocytes fail to induce COX-2 expression regardless of the pro-inflammatory factors used. COX-2 is induced in hepatocytes after partial hepatectomy (PH), in animal models of cirrhosis, in human hepatoma cell lines, in human HCC and after HBV and HCV infection. However, no data are available regarding 15-PGDH expression in HCC. Our results show that 15-PGDH is downregulated in human hepatoma cells with a high COX-2 expression, in chemical and genetic murine models of HCC and in human HCC biopsies. Moreover, 15-PGDH expression is suppressed by EGF (epidermal growth factor) and HGF (hepatocyte growth factor) mainly involving PI3K (phosphatidylinositol-3-kinase), ERK (extracellular signal-regulated kinase) and p38MAPK (mitogen-activated protein kinase) activation. Conversely, ectopic expression of 15-PGDH induces apoptosis in hepatoma cells and decreases the growth of hepatoma cells in nude mice whereas the silencing of 15-PGDH increases the tumor formation. These data suggest a potential therapeutic application of 15-PGDH in HCC. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
28. Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells.
- Author
-
Cariaga-Martinez, Ariel E., López-Ruiz, Pilar, Nombela-Blanco, M. Paz, Motiño, Omar, González-Corpas, Ana, Rodriguez-Ubreva, Javier, Lobo, María V.T., Cortés, M. Alicia, and Colás, Begoña
- Subjects
- *
PROTEIN kinase B , *PROSTATE cancer , *ANDROGENS , *ONCOGENES , *GENE expression , *CANCER cells , *CELL growth , *CELL migration - Abstract
Abstract: AKT isoforms are expressed in prostate cancer and their expression and localization have different associations with clinical characteristics. However, the distinct roles of the AKT isoforms in prostate cancer cells are largely unknown. In the present study, we demonstrate distinct roles for AKT1 and AKT2 in cell growth and migration. Ablation of AKT1 and AKT2 decreased the proliferation of the androgen-independent cell line PC-3, although by different mechanisms. AKT1 ablation induced loss of cell adhesion and subsequent apoptosis. AKT2 (but not AKT1) ablation promoted cell cycle arrest at G0/G1, associated with downregulation of cyclin D, CDK6 and CDK2, and upregulation and cytoplasmic-to-nuclear redistribution of p27. The increase of p27 protein levels was due to more gene transcription and an increase in protein stability. The increased stability of p27 was induced by delocalisation of Skp2 and a lower level of p27 phosphorylation at Thr187. AKT1 and AKT2 ablation inhibited and stimulated PC-3 cell migration, respectively. An AKT isoform-specific function could be associated with its subcellular localization. We found that AKT1 and AKT2 were mainly localised in the cytoplasm and nucleus, respectively. In androgen-sensitive cell line LNCaP, the ablation of AKT1 or AKT2 caused apoptosis but in androgen-independent LNCaP sublines, the effect of AKT1 ablation was lower; whereas no changes were observed after AKT2 ablation. Taken together, our data show that AKT1 and AKT2 have non-redundant roles in the regulation of PC-3 cell proliferation and migration. These could be explained by their subcellular localization and/or the specific regulation of downstream effectors. Furthermore, contribution of AKT isoforms to the progression of prostate cancer may change from an androgen-sensitive to a hormone-refractory stage. These findings may help design new targeted strategies for inhibiting AKT isoforms in prostate cancer. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.